Cited by 261Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

The Insulin Resistance—Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients' Risk

Open access
Després, Jean‐Pierre·1998·Obesity Research

Abstract

Coronary heart disease (CHD) and type 2 diabetes mellitus represent two highly prevalent conditions in affluent societies. Although a dyslipidemic state is frequently found in type 2 patients with obesity, studies have shown that the high triglyceride, low high‐density lipoprotein (HDL) cholesterol dyslipidemia is also found in nondiabetic patients with insulin resistance. Studies that have used imaging techniques to assess the regional distribution of body fat have shown that an excess of visceral adipose tissue, that is, a high accumulation of fat in the abdominal cavity, was associated with a cluster of metabolic disturbances such as insulin resistance, hyperinsulinemia, glucose intolerance, hypertriglyceridemia, elevated apolipoprotein B (apoB) concentrations, small, dense low‐density lipoprotein (LDL) particles, as well as low HDL cholesterol levels. Prospective studies such as the Quebec Cardiovascular Study have shown that this cluster of metabolic abnormalities commonly found in patients with excess visceral adipose tissue substantially increases the risk of CHD. The high prevalence of visceral obesity in sedentary adult men and postmenopausal women is such that it may represent the most prevalent cause of atherogenic dyslipidemic states associated with CHD in our population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1550-8528.1998.tb00683.x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The commonly observed relationship between increased VAT and metabolic disease is because of the correlation between VAT and IHTG.

    “and suggest the commonly observed relationship between increased VAT and metabolic disease (1-4) is because of the correlation between VAT and IHTG (8)(9)(10).”
  • An increase in VAT is associated with impaired glucose tolerance, insulin resistance, and increased VLDL-TG secretion.

    “data from metabolic studies conducted on human subjects (3,4) indicate that an increase in VAT is associated with impaired glucose tolerance, insulin resistance, and increased very-low-density lipoproteintriglyceride (VLDL-TG) secretion.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. Vague J. La diffkrenciation sexuelle, facteur dkterminant des formes de I'obCsit.6. Presse Medicale. 1947;30:339-340.
  2. Desprks J-P. Dyslipidemia and obesity. Ballitre's Clin En- docrinol Metab. 1994;8:629-660.
  3. Kissebah AH, Evans DJ, Peiris A, Wilson CR. Endocrine characteristics in regional obesities: Role of sex steroids. In: Vague J, Bjorntorp B, Guy-Grand B, et al., eds. Metabolic Complications of Human Obesities. Amsterdam: Elsevier Sci- ence Publishers; 1985;115-130.
  4. Kissebah AH, Krakower GR. Regional adiposity and mor- bidity. Physiol Rev. 1994;74:761-811.
  5. 17B-22B. 16s OBESITY RESEARCH Vol. 6 Suppl. 1 April 1998 15508528, 1998, S1, Insulin Resistance-Dyslipidernic Syndrome, Despres 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. · DOI
  6. O'Brien T, Nguyen TT, Hallaway BJ, et al. The role of lipoprotein A-I and lipoprotein A-VA-I1 in predicting coro- nary heart disease. Arterioscler Thromb Vasc Biol. 1995;15: 228-23
  7. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation. 1997;95:69-75.

Cited by

Sorted by citations

Authors
Després, J.
Affiliations
Centre hospitalier de l'Université Laval (CA)
Corresponding author
Després, Jean‐Pierre
Venue
Obesity Research
Publisher
Wiley
Published
1998-04
Volume
6
Issue
S1
Pages
8S-17S
ISSN
  • 1071-7323 (ISSN-L)
  • 1550-8528
OpenAlex
W2067880100
Cited by
261
References
55
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 12 · 2015: 4 · 2014: 10 · 2013: 8 · 2012: 16
FWCI
3.42
Type
journal article
Language
en
Open access
Locations
  • Obesity Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Canadian Diabetes Association
  • Medical Research Council Canada
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
insulin resistance, visceral obesity, dyslipidemia, coronary artery disease, type 2 diabetes, hypertriglyceridemia, low HDL cholesterol, visceral adipose tissue, atherogenic dyslipidemia, cardiovascular risk, apolipoprotein B, small dense LDL, hyperinsulinemia, impaired glucose tolerance
MeSH terms
Adipose Tissue, Cardiovascular Diseases, Humans, Hyperlipidemias, Insulin Resistance, Obesity, Risk Factors, Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review